Artificial Intelligence In Remote Patient Monitoring Market Scope
AI and remote patient monitoring is a powerful tools to give providers insight into the day-to-day factors that may be impacting an individual’s health AI can be leveraged to yield more successful remote patient monitoring programs before they even begin. Advanced algorithms can analyze large data sets like clinical, socioeconomic, and experiential data for a more holistic view of an individual. Based on this analysis, stratification can occur to identify not only risk levels, but to gain a better understanding of which individuals would respond most optimally to remote patient monitoring.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Dexcom (United states), Honeywell Life Sciences (United States), Medtronic (Ireland), Philips Healthcare (Netherlands), ResMed (United States), Senseonics (United States), GYANT (United States), Medopad (United Kingdom), Chronisense Medical (Israel), Ejenta (United States) and Cardiomo, Inc. (United States) |
CAGR | % |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Dexcom (United states), Honeywell Life Sciences (United States), Medtronic (Ireland), Philips Healthcare (Netherlands), ResMed (United States), Senseonics (United States), GYANT (United States), Medopad (United Kingdom), Chronisense Medical (Israel), Ejenta (United States) and Cardiomo, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are 100 Plus (United States), Vitls (United States) and Neteera (Israel).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Artificial Intelligence In Remote Patient Monitoring market by Type , by Application (Wearable heart monitors, Bluetooth-enabled scales, Glucose monitors and Maternity care trackers) and Region with country level break-up.
On the basis of geography, the market of Artificial Intelligence In Remote Patient Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2022.
Market Leaders and their expansionary development strategies
On 24 August 2021 Connect America has signed an agreement to acquire 100Plus, a remote patient monitoring platform that uses artificial intelligence.The pairing of the two companies joins together Connect America's Personal Emergency Response Services (PERS) with 100Plus's and proven RPM solutions onto one care management platform.
On 03 August 2021 CareVention HealthCare, a division of Tabula Rasa HealthCare, launched a remote patient monitoring service that uses biosensors and artificial intelligence to monitor patients’ vital signs and alert health care providers if necessary. and On 17 august 2021 Medical technology company Qardio has announced the launch of an end-to-end remote patient monitoring (RPM) and telehealth service called Qardio Direct.
Influencing Trend:
Technical progress in medical industry
Market Growth Drivers:
Increasing clinical trial for remote patient monitoring
Challenges:
Fierce competitive pressure
Restraints:
Technological limitations and Cost Concerns
Opportunities:
Growth in healthcare infrastructure due to pandemic
Key Target Audience
Artificial Intelligence In Remote Patient Monitoring Manufactures, New Entrants and Investors, Artificial Intelligence In Remote Patient Monitoring Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others